Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment crawled date : 2020 - 12 - 02 save search
Protagonist's Hepcidin Mimetic Candidate PTG-300 Receives Fast Track Designation from the U.S. Food and Drug Administration for Development in the Treatment of Polycythemia Vera
Published: 2020-12-02 (Crawled : 17:00) - biospace.com/
PTGX S | $26.85 0.9% 0.78% 5
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: -6.23%
food drug treatment fast track fast track designation designation
Brickell Biotech Announces Approval of Sofpironium Bromide Gel, 5% in Japan for Treatment of Primary Axillary Hyperhidrosis Received by its Development Partner, Kaken Pharmaceutical
Published: 2020-09-25 (Crawled : 16:01) - globenewswire.com
BBI | $2.12 16.04%
|
Health Technology
|
| O: 10.26%
H: 1.74%
C: -5.77%
biotech approval treatment
Brickell Biotech Announces Initiation of U.S. Phase 3 Program Evaluating Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis
Published: 2020-10-06 (Crawled : 16:01) - globenewswire.com
BBI | $2.12 16.04%
|
Health Technology
|
| O: 2.25%
H: 2.2%
C: 1.1%
biotech phase 3 treatment
Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degeneration
Published: 2020-12-02 (Crawled : 15:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.03% 140K
|
Health Technology
|
| O: 0.27%
H: 1.26%
C: 0.2%
therapy gene therapy macular treatment gene therapies
Update on Remestemcel-L For the Treatment of COVID-19 ARDS and Steroid-Refractory Acute GVHD
Published: 2020-10-29 (Crawled : 14:26) - globenewswire.com
MESO | $6.0 8.5% 7.37% 2.9K
|
Health Technology
|
| O: 4.22%
H: 1.75%
C: 0.37%
covid treatment covid-19
Nabriva Therapeutics Receives Positive EU CHMP Opinion for XENLETA™ (lefamulin) for the Treatment of Community-Acquired Pneumonia (CAP)
Published: 2020-05-29 (Crawled : 13:47) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 2.95%
H: 36.92%
C: 30.08%
positive acquired treatment chmp lefamulin
XENLETA® (lefamulin) Receives Health Canada Approval for Treatment of Community Acquired Pneumonia
Published: 2020-07-16 (Crawled : 13:47) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 15.61%
H: 1.74%
C: -6.11%
acquired approval treatment lefamulin health
NABRIVA Receives European Approval for XENLETA® (lefamulin) for Treatment of Community-Acquired Pneumonia (CAP)
Published: 2020-07-28 (Crawled : 13:47) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: -1.23%
H: 11.87%
C: 2.5%
acquired approval treatment lefamulin
Medicenna Hosting Key Opinion Leader Call on MDNA55 for the Treatment of Recurrent Glioblastoma Multiforme
Published: 2020-12-02 (Crawled : 12:01) - globenewswire.com
MDNA | $0.157 -0.32% 1.3M
|
Health Technology
|
| O: -1.04%
H: 3.67%
C: 3.29%
treatment glioblastoma
FDA Grants Fast Track Designation for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19
Published: 2020-12-02 (Crawled : 11:01) - globenewswire.com
MESO | $6.0 8.5% 7.37% 2.9K
|
Health Technology
|
| O: 9.19%
H: 0.91%
C: -4.05%
covid respiratory fda treatment fast track fast track designation syndros granted grant designation
Axsome Therapeutics Announces Positive Results from the COMET-TRD Trial of AXS-05 in Patients with Treatment Resistant Depression
Published: 2020-12-02 (Crawled : 11:01) - globenewswire.com
AXSM | $73.08 2.79% 2.68% 0
|
Health Technology
|
| O: 0.66%
H: 3.28%
C: 2.84%
positive results depression positive results trial treatment
BioCryst’s Oral Factor D Inhibitor, BCX9930, Shows Clinical Benefit as Monotherapy Through 400 mg bid in Treatment-naïve PNH Patients
Published: 2020-09-30 (Crawled : 10:18) - globenewswire.com
BCRX | News | $4.38 -0.68% -0.8% 3.6M
|
Health Technology
|
| O: -1.17%
H: 0.79%
C: -9.37%
therapy treatment
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
YSG | $4.09 4.07% 30K
|
Manufacturing
YMM | $8.45 3.55% 210K
|
Transportation and Warehousing
ZTO | $20.72 2.37% 87K
|
Transportation
ABNB | $164.76 2.37% 130K
|
Administrative and Support and ...
ZS | $179.5 1.46% 34K
|
Technology Services
Z | $43.93 0.69% 28K
|
Technology Services
ZM S | $61.88 0.42% 56K
|
Technology Services
ZUO 4 | $9.76 0.1% 21K
|
Technology Services
ZG | $43.15 -0.07% 5.9K
|
Technology Services
ZTS | $149.41 -0.1% 220K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.